• Extremely American

Dr David Martin: "The term 'mRNA vaccination' was hijacked & intended to mislead/confuse the public"



Interview notes transcribed by: Rhoda Wilson


During a recent interview Dr David E. Martin discussed a federal lawsuit filed on 3 March in Utah against: Joe Biden; the director of the Health and Human Services (“HHS”); the Medicare and Medicaid directors; and, the Centers for Medicare and Medicaid Services (“CMS”) Mandate directors.


Patrick Gentempo, creator of "Covid Revealed", interviewed Dr. David Martin earlier this month where he explained:


“The body becomes a biological weapons factory, manufacturing the spike protein, a scheduled pathogen with genetic sequences derived from SARS-CoV-2: a known toxin on the list of scheduled bioweapons in the US code."


“The injection does not stimulate any immunity to SARS-CoV-2. At best you’re getting immunity to the first variation of the computer simulated first spike protein that was first thought to be associated with SARS-CoV-2. The only thing you could have alleged to get immunity to was the first fragment of spike protein from the first model.”


“This suit very specifically says that using the term ‘vaccination’ was intended to, essentially, mislead the public. It was meant to confuse. It was meant to build an expectation that cannot be met."


“Not only did that ‘vaccination’ term get hijacked, [but] it should have been called – what in fact it was called in the SEC filings of both Pfizer-BioNTech and Moderna – a gene therapy."


“This first lawsuit gives rise to a series of other lawsuits which ultimately end in the discovery of the criminal conspiracy that I’ve been talking about for a long time. Because the way we laid the case down – in discovery, we are going to get evidence of the felony. And in the next case we’re going to get more disclosure of the felony."


“We wrote this case so that their responses in our case are in fact going to be incriminating for our next case. So, we wrote this case so that their response is an admission of the next crime, and of the next crime … [The end] is to make sure we get the felony convictions and perpetrators of this crime so that the immunity shield falls away from the manufactures and all of the injuries and all of the deaths from the injection become civil liabilities to the manufacturers."


Source: Open Source Truth


Dr. David E. Martin Biography


Dr. David E. Martin is the Founder and Chairman of M·CAM Inc., the international leader in innovation finance, trade, and intangible asset finance. He is the developer of the first innovation-based quantitative index of public equities and is the Managing Partner of the Purple Bridge Funds. He is the creator of the world’s first quantitative public equity index – the CNBC IQ100 powered by M·CAM. Actively engaged in global ethical economic development, Dr. Martin’s work includes financial engineering and investment, public speaking, writing and providing financial advisory services to the majority of countries in the world. Dr. Martin is the architect and founder of the Global Innovation Commons and is the author of the international legal framework for the Heritable Knowledge Trust and Heritable Innovation Trust programs. He has pioneered global programs to bring corporate and stock market transparency to multi-national extractive industries and has been instrumental in repatriating value to countries which have been subject to corporate and financial abuses.


His work on ethical engagement and stewardship of community and commons-based value interests is at the forefront of global financial innovation. Dr. Martin is a Batten Fellow at the University of Virginia’s Darden Graduate School of Business Administration. He served as Chair of Economic Innovation for the UN-affiliated Intergovernmental Renewable Energy Organization and has served as an advisor to numerous Central Banks, global economic forums, the World Bank and International Finance Corporation, and national governments.


A spokesperson for global financial and intangible asset accountability and quality reform, Dr. Martin has worked closely with the United States Congress and numerous trade and financial regulatory agencies in the United States, Europe, and Asia in advocating and deploying infrastructure to support growing reliance on contract and proprietary rights in business transactions. Under the leadership of Dr. Martin, M·CAM has supported the modernization of banking, intangible asset, tax, and accounting laws through its work with oversight agencies and policy makers.


Dr. Martin has founded several for-profit and not-for-profit companies and organizations and serves on several boards. He was a Co-Chair of the ADC (Australia Davos Connection) Forum’s Leadership Retreat and Critical Infrastructure and Cybersecurity Councils. He was the founding Director of Melbourne’s Centre of Applied Innovation. He served as Chairman and CEO of eSurface®. He was the founding CEO of Mosaic Technologies, Inc., a company that developed and commercialized technologies in advanced computational linguistics, dynamic data compression and encryption, electrical field transmission, medical diagnostics, and stealth/anechoic. He was a founding member of Japan’s Institute for Interface Science and Technology (IIST). He founded and served as Executive Director of the Charlottesville Venture Group. He has served as a board member for the Research Institute for Small and Emerging Business (Washington, D.C.), the Academy for Augmenting Grassroots Technological Innovations (India), the Charlottesville Regional Chamber of Commerce (Virginia), and the Charlottesville Industrial Development Agency (Virginia), Humanitad (U.K), Global Urban Development, and many other agencies dedicated to ethical human development. As international policy contributor, economist and futurist, Dr. Martin’s work at The Arlington Institute (U.S.) included accurately forecasting the global financial crisis of 2008 and working with the launch of Singapore’s Risk Assessment Horizon Scanning initiative.

Dr. Martin’s work as a Fellow of the Batten Institute at the Darden Graduate School of Business Administration at the University of Virginia and his related work at the Indian Institute for Management Ahmedabad, India, has brought unprecedented curricular focus to areas of intangible-asset risk management, finance, and accounting standards. In addition to his academic work, Dr. Martin has closely advised innovation-based finance and investment programs in India, Bermuda, Brazil, China, Denmark, the European Union, the United Kingdom, South Africa, the Islamic Republic of Iran, the United States, Mongolia, Egypt, Ecuador, Singapore, Germany, Slovenia, Vietnam, and the United Arab Emirates. He has served as the Constitutional and Economic advisor to the Autonomy Committee of East New Britain and New Ireland, Papua New Guinea and has worked with ethical trade frameworks for the Kingdom of Tonga, the Independent State of Samoa, Fiji, and Papua New Guinea.


His work has been the subject of two internationally awarded documentaries, Patent Wars which highlights his work on reform of the global innovation system and Future Dreaming: A Conversation with David Martin which is a dialogue about humanity and its optimal interaction in the universe. He has spoken at the United Nations General Assembly on citizen-led peacemaking initiatives and has been featured on Bloomberg television and HBO’s Last Week Tonight with John Oliver.


A speaker, author, business executive and futurist, Dr. Martin’s work has been engaged in every country on Earth. He works with his family in every endeavor of life. Together with his wife Kim, he directs the Breathing Enterprise workshops and facilitates implementation of Integral Accounting. Dr. Martin received his undergraduate (BA) from Goshen College, his Masters of Science from Ball State University, and his Doctorate (PhD) from the University of Virginia.